141080 — Legochem Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩2tn
- KR₩2tn
- KR₩34bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 12,476 | -6,986 | -23,391 | -45,092 | -73,704 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | -1,371 | -2,522 | 3,058 | 13,365 | 5,443 |
Unusual Items | |||||
Purchased R&D | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 9,144 | -8,380 | -24,765 | 20,475 | 1,353 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 24,113 | -14,893 | -42,049 | -7,136 | -62,236 |
Capital Expenditures | -3,491 | -3,219 | -18,603 | -4,772 | -2,202 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 33,463 | 3,568 | -25,341 | -11,397 | 11,569 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 29,971 | 349 | -43,944 | -16,169 | 9,367 |
Financing Cash Flow Items | -1.25 | -157 | -26.3 | -2.64 | -4.21 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,601 | 2,633 | 171,292 | 3,199 | -1,909 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 56,667 | -12,240 | 85,291 | -21,975 | -54,911 |